Robert M. Patterson - 17 Feb 2023 Form 4 Insider Report for AVIENT CORP (AVNT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Feb 2023, 10:50:03 UTC
Prior SEC filing
14 Feb 2023
Next SEC filing
01 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lisa K. Kunkle, Power of Attorney For: Robert M. Patterson

Key filing fact

Robert M. Patterson filed Form 4 for AVIENT CORP (AVNT) on 21 Feb 2023.

Key facts

  • This page summarizes Robert M. Patterson's Form 4 filing for AVIENT CORP (AVNT).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 21 Feb 2023, 10:50.

Change

  • Previous filing in this sequence was filed on 14 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVNT transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+46,750
Change %
Price
$0.000000
Shares after
46,750
Date
17 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
46,750
Exercise price
Footnotes
F1
AVNT transaction Derivative

Stock Appreciation Rights

Award

Transaction value
$0
Shares
+158,450
Change %
Price
$0.000000
Shares after
158,450
Date
17 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
158,450
Exercise price
$42.93
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Avient common stock.

Footnote F2

SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .